These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26206626)

  • 1. Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries.
    Hunter CA; Kirson NY; Desai U; Cummings AK; Faries DE; Birnbaum HG
    Alzheimers Dement; 2015 Aug; 11(8):887-95. PubMed ID: 26206626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
    Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
    J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the economic burden of Alzheimer's disease patients first diagnosed by specialists.
    Kirson NY; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Ye W; Andrews JS; Ball D; Kahle-Wrobleski K
    BMC Geriatr; 2016 Jul; 16():138. PubMed ID: 27400711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, resource utilization and costs of vascular dementia compared to Alzheimer's dementia in a population setting.
    Sicras A; Rejas J; Arco S; Flores E; Ortega G; Esparcia A; Suárez A; Gordillo MJ
    Dement Geriatr Cogn Disord; 2005; 19(5-6):305-15. PubMed ID: 15785031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease.
    Kaltenboeck A; Johnson SJ; Davis MR; Birnbaum HG; Carroll CA; Tarrants ML; Siderowf AD
    Parkinsonism Relat Disord; 2012 May; 18(4):321-6. PubMed ID: 22177623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.
    Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
    Appl Health Econ Health Policy; 2013 Aug; 11(4):407-13. PubMed ID: 23700254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Pathways to Alzheimer Disease: Costs Incurred in a Medicare Population.
    Gilden DM; Kubisiak JM; Sarsour K; Hunter CA
    Alzheimer Dis Assoc Disord; 2015; 29(4):330-7. PubMed ID: 25635340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.
    Zhao Y; Kuo TC; Weir S; Kramer MS; Ash AS
    BMC Health Serv Res; 2008 May; 8():108. PubMed ID: 18498638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.
    Fillit H; Hill JW; Futterman R
    Fam Med; 2002; 34(7):528-35. PubMed ID: 12144008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.
    Suehs BT; Davis CD; Alvir J; van Amerongen D; Pharmd NC; Joshi AV; Faison WE; Shah SN
    Am J Alzheimers Dis Other Demen; 2013 Jun; 28(4):384-92. PubMed ID: 23687180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
    Hill JW; Futterman R; Duttagupta S; Mastey V; Lloyd JR; Fillit H
    Neurology; 2002 Jan; 58(1):62-70. PubMed ID: 11781407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direct health care cost to Medicare of Down syndrome dementia as compared with Alzheimer's disease among 2015 Californian beneficiaries.
    Bayen E; Yaffe K; Cleret de Langavant L; Chen Y; Possin KL
    Ann Phys Rehabil Med; 2021 Jan; 64(1):101430. PubMed ID: 32853759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of early treatment among Medicaid patients with Alzheimer's disease.
    Geldmacher DS; Kirson NY; Birnbaum HG; Eapen S; Kantor E; Cummings AK; Joish VN
    Alzheimers Dement; 2014 Mar; 10(2):214-24. PubMed ID: 23643457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.
    Nair R; Haynes VS; Siadaty M; Patel NC; Fleisher AS; Van Amerongen D; Witte MM; Downing AM; Fernandez LAH; Saundankar V; Ball DE
    BMC Geriatr; 2018 Oct; 18(1):243. PubMed ID: 30326851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer's Disease.
    Yang Z; Levey A
    Womens Health Issues; 2015; 25(5):436-40. PubMed ID: 26363924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2011 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2011 Mar; 7(2):208-44. PubMed ID: 21414557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of comorbidity on costs for patients with Alzheimer disease.
    Kuo TC; Zhao Y; Weir S; Kramer MS; Ash AS
    Med Care; 2008 Aug; 46(8):839-46. PubMed ID: 18665064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The costs of vascular dementia: a comparison with Alzheimer's disease.
    Fillit H; Hill J
    J Neurol Sci; 2002 Nov; 203-204():35-9. PubMed ID: 12417354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.